Should ophtalmologists recommend medical cannabis to patients with glaucoma?

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Should ophtalmologists recommend medical cannabis to patients with glaucoma? / Mouhammad, Zaynab Ahmad; Kolko, Miriam.

In: Ugeskrift for Laeger, Vol. 180, No. 5, 2019, p. 2-6.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Mouhammad, ZA & Kolko, M 2019, 'Should ophtalmologists recommend medical cannabis to patients with glaucoma?', Ugeskrift for Laeger, vol. 180, no. 5, pp. 2-6.

APA

Mouhammad, Z. A., & Kolko, M. (2019). Should ophtalmologists recommend medical cannabis to patients with glaucoma? Ugeskrift for Laeger, 180(5), 2-6.

Vancouver

Mouhammad ZA, Kolko M. Should ophtalmologists recommend medical cannabis to patients with glaucoma? Ugeskrift for Laeger. 2019;180(5):2-6.

Author

Mouhammad, Zaynab Ahmad ; Kolko, Miriam. / Should ophtalmologists recommend medical cannabis to patients with glaucoma?. In: Ugeskrift for Laeger. 2019 ; Vol. 180, No. 5. pp. 2-6.

Bibtex

@article{41d1194ee12d4262a11c12dbb4f34f4e,
title = "Should ophtalmologists recommend medical cannabis to patients with glaucoma?",
abstract = "Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both Δ-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.",
author = "Mouhammad, {Zaynab Ahmad} and Miriam Kolko",
note = "Publisher Copyright: {\textcopyright} 2019, Ugeskrift for Laeger. All Rights Reserved.",
year = "2019",
language = "English",
volume = "180",
pages = "2--6",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "5",

}

RIS

TY - JOUR

T1 - Should ophtalmologists recommend medical cannabis to patients with glaucoma?

AU - Mouhammad, Zaynab Ahmad

AU - Kolko, Miriam

N1 - Publisher Copyright: © 2019, Ugeskrift for Laeger. All Rights Reserved.

PY - 2019

Y1 - 2019

N2 - Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both Δ-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.

AB - Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both Δ-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.

UR - http://www.scopus.com/inward/record.url?scp=85127867145&partnerID=8YFLogxK

M3 - Journal article

AN - SCOPUS:85127867145

VL - 180

SP - 2

EP - 6

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 5

ER -

ID: 320012582